| CXHB1800058 | 甲磺酸艾氟替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs | Supplementary Application | 2018-08-17 | 上海艾力斯医药科技有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | Certificate Issued | 2018-10-29 | view |
| CXHB1800059 | 甲磺酸艾氟替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs | Supplementary Application | 2018-08-17 | 上海艾力斯医药科技有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | Certificate Issued | 2018-10-29 | view |
| CXHB2200186 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-11-08 | | | | | view |
| CXHL1502428 | 甲磺酸艾氟替尼 | furmonertinib mesilate | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2016-01-25 | 上海艾力斯医药科技有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | Certificate Issued | 2016-09-03 | view |
| CXHL1502429 | 甲磺酸艾氟替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-01-25 | 上海艾力斯医药科技有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | Certificate Issued | 2016-09-03 | view |
| CXHL2000557 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-11-05 | 上海艾力斯医药科技股份有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | In Review | 2020-11-04 | view |
| CXHL2100184 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2021-03-16 | 上海艾力斯医药科技股份有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | In Review | 2021-03-15 | view |
| CXHL2101030 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2021-04-14 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2200361 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2022-06-08 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2300095 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-01-19 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2300110 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-01-20 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2300625 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-06-08 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2400411 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2024-04-23 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2400492 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2024-05-16 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHL2401238 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2024-11-15 | | Shanghai Allist Pharmaceuticals Co Ltd | | | view |
| CXHS1900039 | 甲磺酸艾氟替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1) | New Drug Application | 2019-12-10 | 江苏艾力斯生物医药有限公司 | Jiangsu Allist Pharmaceutical Co Ltd | Certificate Issued | 2021-03-08 | view |
| CXHS2101055 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2021-12-17 | | | | | view |
| CYHB2200947 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-06-14 | | | | | view |
| CYHB2400454 | 甲磺酸伏美替尼片 | furmonertinib mesilate | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-04-02 | | | | | view |
